title: [A novel molecular target therapeutics for refractory prostate cancer].
authors.affiliation: Department of Urology, Yokohama City University School of Medicine.
authors.forename: Hiroji
authors.initials: H
authors.lastname: Uemura
authors.forename: Naoya
authors.initials: N
authors.lastname: Ikeda
authors.forename: Noboru
authors.initials: N
authors.lastname: Nakaigawa
authors.forename: Hideki
authors.initials: H
authors.lastname: Ouchi
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Ishiguro
authors.forename: Yoshinobu
authors.initials: Y
authors.lastname: Kubota
mesh_terms: D000077556:Alitretinoin; D000728:Androgens; D057911:Angiotensin Receptor Antagonists; D000818:Animals; D001562:Benzimidazoles / Q000627:therapeutic use; D001713:Biphenyl Compounds; D002762:Cholecalciferol / Q000627:therapeutic use; D004268:DNA-Binding Proteins; D015195:Drug Design; D019833:Genistein / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy* / Q000209:etiology; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000209:etiology; D044140:Receptor, Angiotensin, Type 1; D011945:Receptors, Angiotensin / Q000502:physiology; D019098:Telomerase / Q000037:antagonists & inhibitors; D013777:Tetrazoles / Q000627:therapeutic use; D014212:Tretinoin / Q000627:therapeutic use
chemical_list: D000728:Androgens; D057911:Angiotensin Receptor Antagonists; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D004268:DNA-Binding Proteins; D044140:Receptor, Angiotensin, Type 1; D011945:Receptors, Angiotensin; D013777:Tetrazoles; D002762:Cholecalciferol; D000077556:Alitretinoin; D014212:Tretinoin; D019833:Genistein; D019098:Telomerase; C081643:candesartan